Tem­pus founders build a drug dis­cov­ery start­up, Pathos AI, with $40M in sight

Ex­ec­u­tives be­hind AI and pre­ci­sion med­i­cine start­up Tem­pus are putting to­geth­er an­oth­er AI out­fit in Chica­go fo­cused on on­col­o­gy drug dis­cov­ery and de­vel­op­ment.

Pathos AI is cur­rent­ly in the works and at­tempt­ing to raise about $40 mil­lion, per an SEC fil­ing from this week. List­ed on the pa­per­work are Tem­pus CEO Er­ic Lefkof­sky and op­er­at­ing chief Ryan Fukushi­ma, who is de­scribed as CEO of Pathos. Lefkof­sky co-found­ed Groupon, is a trustee of many mar­quee Chica­go in­sti­tu­tions and co-man­ages the Mid­west VC firm Light­bank, which is cur­rent­ly look­ing to raise $250 mil­lion for its third fund, per an­oth­er doc­u­ment filed with the SEC last No­vem­ber.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER